Meningeal Carcinomatosis - 23 Studies Found
| Not yet recruiting |
: Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis : Meningeal Carcinomatosis : 2015-10-26 : Drug: methotrexate The quantity of methotrexate is different in the two groups. |
| Terminated |
: Depocyt® With Sorafenib in Neoplastic Meningitis : Neoplastic Meningitis : 2009-08-24 :
|
| Completed |
: A Pilot Study of Bevacizumab for Neoplastic Meningitis : Neoplastic Meningitis : 2009-06-18 : Drug: Bevacizumab 10 mg/kg by vein over about 1 hour, every 2 weeks. |
| Terminated |
: DepoCyt Plus Temozolomide in Patients With Neoplastic Meningitis : Neoplastic Meningitis : 2007-08-13 :
|
| Completed |
: Phase 1 Intrathecal Topotecan for Neoplastic Meningitis : Neoplastic Meningitis : 2007-12-21 :
|
| Terminated |
: A Safety Study of RTA 744 in Recurrent, Progressive or Refractory Neoplastic Meningitis : Leptomeningeal Carcinomatosis : 2007-09-07 : Drug: RTA 744 Aqueous solution of RTA 744 is packaged in 5 ml vials - 1 mg/ ml. The drug is mixed in D10 |
| Terminated |
: Circulating Tumor Cells and Cytology in Cerebrospinal Fluid of Patients Clinically Suspected for Leptomeningeal Metastases : Meningeal Carcinomatosis : 2012-10-22 : Procedure: lumbar puncture |
| Terminated |
: DepoCyt for Active Lymphomatous or Leukemic Meningitis :
: 2007-08-31 : Drug: cytarabine liposome injection 50 mg intrathecal every 14 days for 8 doses, then every 28 days for |
| Completed |
: Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis :
: 2011-05-24 : Drug: Trastuzumab One injection per week during 8 weeks by lumbar puncture or Ommaya Reservoir. 4 levels |
| Completed |
: Clinical and Pharmacological Study With 2B3-101 in Patients With Breast Cancer and Leptomeningeal Metastases : Meningeal Carcinomatosis : 2013-03-18 : Drug: 2B3-101 50 mg/m2 2B3-101 intravenous 3-weekly administration |